Skip to main content

News

SunHydrogen and CTF Solar sign agreement to accelerate hydrogen panel manufacturing

SunHydrogen, Inc., the developer of a breakthrough technology that produces renewable hydrogen using only sunlight and water, announced the signing of a Technology and Manufacturing Services agreement with CTF Solar GmbH, a subsidiary of China National Building Materials Group (CNBM).

The agreement is designed to accelerate the industrialization of SunHydrogen’s proprietary hydrogen panel technology by rapidly converting pilot data and recent process learnings into a controlled manufacturing workflow. This partnership is designed to fast-track the transition from pilot-scale to production-scale, with the near-term goal of producing 1,000 full size 1.92 m² hydrogen modules, laying the groundwork for commercial deployment.

The signing ceremony was held at CTF Solar’s headquarters in Dresden, Germany. The agreement was signed by Tim Young, Chief Executive Officer of SunHydrogen, Inc., along with Bastian Siepchen, Chief Executive Officer of CTF Solar GmbH, and Jens Heinrich, Director of Technology Development at CTF Solar GmbH, on behalf of their respective companies.

This agreement follows the expanded Memorandum of Understanding announced on November 18, 2025, and builds on prior collaboration agreements signed in December 2023 and July 2024. It establishes a contracted manufacturing development program with defined scope, deliverables, and validation objectives, effectively locking in the path to mass production.

“This is a major milestone for us. We’re taking what we’ve built in the lab and setting it up for real-world production, with a focus on doing it consistently and at scale. We are working with our partner CTF Solar to get ready to build up to 1,000 full size hydrogen panels and to do it right,” said Tim Young, Chief Executive Officer of SunHydrogen, Inc. “This agreement represents an important step toward industrializing our hydrogen module design through controlled manufacturing with consistent quality. As we advance this manufacturing capability, our objective is to support customer engagement and position the company to secure an initial offtaker for our technology within the coming year.”

“This is an important milestone for both teams. We’re excited to continue as SunHydrogen’s partner as they move from pilot-scale development toward a manufacturing framework that can meet future commercial requirements. Our job now is to support that transition with a clear manufacturing roadmap,” said Bastian Siepchen, Chief Executive Officer of CTF Solar GmbH.